This product is a rapid direct binding test kit for Cardiac Troponin I. Results are available in 10-20 minutes. It is very sensitive and easy for storage.

About Us

Getein Biotechnology Co., Ltd. is a manufacturer of medical rapid test products, with certification of CE&ISO 13485, OEM/ODM service offered. It is founded in March 2002, located in Zhongshan Science and Technology Park, Nanjing, China, with construction area of 17,000 square meters.

 As the leader in POCT field, our leading products include Cardiac Markers Rapid Test Kits and advanced clinical diagnostic device Quantitative Immunoassay Analyzer. Our products are suitable for cardiovascular and cerebrovascular diseases, oncosis, kidney trouble and other diseases. We are looking for suitable distributors worldwide. Welcome to join us!

Intended Use

The Cardiac Troponin I Fast Test Kit (colloidal gold) is intended for use together with the FIA8000 Quantitative Immunoassay Analyzer. It can be used to detect Cardiac Troponin I (cTnI) in human serum, plasma or whole blood specimens in vitro quantitatively.

This test serves as an aid in the diagnosis of patients with suspected myocardial damage such as acute coronary syndrome (ACS), acute myocardial infarction (AMI), Unstable Angina (UA) and Acute Myocarditis.

Principle

This product is based on the principle of sandwich immunoassay for determination of cTnI in human blood specimens. Two monoclonal antibodies are employed to identify cTnI specifically, resulting in a purplish red streak appears on the test line. The color intensity of the test line increases in proportion to the cTnI concentration.

Then insert test card into the FIA8000 Quantitative Immunoassay Analyzer, the concentration of cTnI is measured quantitatively and displayed on the screen. The result can be transmitted to the lab or hospital information system.

Any interests or questions, please contact us.
Tel：+86-25-68568594
E-mail:sales@getein.com.cn
Website:http://www.bio-gp.com.cn/EN/Index.aspx

 

Getein Biotech, Inc. (SSE stock code:603387) is a fully integrated in vitro diagnostic company that develops, manufactures and distributes analytical medical devices as well as a broad range of innovative diagnostic test kits, dedicated to making diagnostics more accessible, more affordable, and more equitable for humanity. Since its foundation in 2002, Getein Biotech has launched 10 advanced technology platforms and possesses more than 200 independent intellectual property products. Headquartered in Nanjing, China, Getein Biotech has grown steadily and rapidly in North and South America, Europe, Africa, and the Asia-Pacific region. At present, the products and services of Getein Biotech are available in over 140 countries.